Kyverna Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $6.01 |
Previous Close | $5.97 |
Day Range | $5.91-$6.19 |
52W Range | $1.78-$7.20 |
Market Cap | $265.1M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$135.9M |
Diluted EPS | -$3.60 |
News
See moreYahoo Finance • 7 hours ago
KYVERNA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation Into Kyverna Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Yahoo Finance • 8 days ago
Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS
About
CEO | Mr. Warner Biddle |
Address | 5980 Horton Street, EmeryVille, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 129 |
